Cargando…
Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions
Monoclonal therapeutic antibodies have revolutionized the treatment of cancer and other diseases. Fc engineering aims to enhance the effector functions or half-life of therapeutic antibodies by modifying their Fc regions. Recent advances in the Fc engineering of modern therapeutic antibodies can be...
Autores principales: | Abdeldaim, Dalia T., Schindowski, Katharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610324/ https://www.ncbi.nlm.nih.gov/pubmed/37896162 http://dx.doi.org/10.3390/pharmaceutics15102402 |
Ejemplares similares
-
Recent Advances and Future Directions in Downstream Processing of Therapeutic Antibodies
por: Matte, Allan
Publicado: (2022) -
Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents
por: van Tetering, Geert, et al.
Publicado: (2020) -
Advanced Hydrogels for Cartilage Tissue Engineering: Recent Progress and Future Directions
por: Hafezi, Mahshid, et al.
Publicado: (2021) -
Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies Through Fc Engineering
por: Ko, Sanghwan, et al.
Publicado: (2021) -
Editorial: Antibody Fc Engineering: Towards Better Therapeutics
por: Lei, Cheng, et al.
Publicado: (2018)